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ABSTACT
Through the review of Scholtissek et al.1, evolution between different strains of influenza A viruses were examined 
to enable better preparation for future pandemics. Pandemics are the result of antigenic shifts, cumulative 
reassortants between circulating viruses that form novel gene sequences. The process may produce a virus 
which a large segment of the population has no immunological memory of, and consequently, are susceptible to 
the strain.
The pandemics in 1918, 1967, 1968 and 2009 were caused by influenza A viruses with hemagglutinin (HA) 
proteins of 1, 2, or 3 - three out of sixteen known HA subtypes. This raises the question whether pandemics 
can contain other HA subtypes. Since influenza viruses have segmented genomes, it may require at least two 
different strains to swap their gene segments in order to co-infect a cell; the better viral compatibility between the 
parent viruses, the more virulent the reassortant is. A collection of HA subtypes in avian strains and Matrix (M) 
protein in human strains were used in the experimental model by Scholtissek et al. to examine the recombinants’ 
survivability and virulence. Although the results conclude that it is not possible for future pandemics to contain 
other HA subtypes, the work of Scholtissek et al. leads to further research on influenza A reservoirs.
Ce document est un résumé au sujet de l’article de Christoph Scholtissek1 publié en 2002. J’examinerai son 
modèle expérimental, en mettant en évidence les résultats et donnant un aperçu des recherches plus élaborées. 
En étudiant des modèles de la coopération entre les virus, ceci permet d’aider à se préparer face aux futures 
pandémies et épidémies. De tels évènements sont causés par des changements antigéniques produits par 
l’accumulation de réassortiments entre les virus en circulation et divers éléments. Les virus grippaux A sont en 
constante évolution, et nécessitent une surveillance constante en anticipation à une pandémie. Les pandémies 
antérieures, soient celles en 1918, 1957, 1968 et 2009, ont démontré à avoir les hémagglutinines (HA) 1, 2 et 
3 – trois des seize sous-types HA possibles. Ceci remet en question la possibilité que les pandémies puissent 
contenir d’autres sous-types HA. Afin que les virus puissent former des virus réassortis potentiellement nouveaux 
ils doivent bien coopérer, ce qui est précisément ce que Scholtissek tente d’enquêter. Son modèle expérimental 
implique des réassortiments entre les différents sous-types d’HA dans des souches aviaires et des souches 
humaines détenant des M-protéines, afin de déterminer la compatibilité virale. Bien que les résultats concluent 
qu’il est très peu probable que de futures pandémies détiennent d’autres sous-types HA, ils fournissent des 
indices du potentiel pandémique. En outre, son article incite la recherche plus à fond sur d’autres réservoirs de 
la grippe A, les méthodes pour surmonter les barrières entre espèces et le réassortiment efficaces.
INTRODUCTION
When influenza viruses co-infect a cell, genetic 
recombination occurs as the new virus obtains 
different traits from both parents. Mutation is 
important for viruses to be able to replicate efficiently, 
as it results in resistance to anti-viral drugs like 
amantadine. Amantadine inhibits M2 ion-channels 
and its related function in viral replication. In order to 
assess recombination, two selection tools were used 
against avian M genes and human HA genes. The 
first, a control and variable virus was used, one being 
amantadine-resistant and the latter being amantadine 
sensitive. The second selection tool was hyperimmune 
antisera, which was used in all the samples. 
Currently, there are 16 known HA subtypes in avian 
influenza A strains.2 Given the previous occurrences 
of 1918 A(H1N1), 1957 A(H2N2) and 1968 A(H3N2), 
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it is known that H1, H2, and H3 can be found in 
influenza A pandemics. HA is an essential component 
in the virus’ genome as it is responsible for viral 
replication. Its functions include the binding of the 
cells’ sialic acid-containing receptors for infection, 
and when the virus undergoes fusion.
The M protein of human influenza A viruses, is split 
up between M1 and M21. The proteins keep the core 
of the virion and its viral envelope intact while also 
being responsible in the viral replication cycle as its 
ion channel permits the uncoating of the virus.3 
Interactions such as the avian strain recombining 
with the human strain require sufficient cooperation, 
where the genes reassort to make a new sequence. 
Cooperation is determined in the experimental model 
when a viable reassortant virus contains the avian HA 
gene and the human M gene, meaning that the HA 
genes of both parent viruses successfully reassorted. 
Studying the compatibility between avian HA and 
human M genes is valuable as it provides clues in 
pandemic potential.
MATERIALS & METHODS
Preparation Before Conducting the Experiment(1)
In order to conduct the experiments, the viruses 
were prepared and plaque-purified in MDCK cells 
before being stocked in 10-day embryonated chicken 
eggs. The amantadine-resistant (Am+) viruses were 
cultured in the presence of 2μg of amantadine before 
further plaque-purification.  A stock of allantoic fluid 
was obtained for each virus strain with the desired 
genetic traits required for the experiment. 
Scholtissek Experimental system testing 
compatibility between Human M-gene and avian 
HA(1) The tables attached shows the MDCK cells 
either singly or doubly infected. Depending on the 
set, either 1:100 or 1:200 ratios were used to dilute 
hyperimmune antisera in PBS. There were three sets 
of experiments conducted:
1. Two different A/PR/8/34 (H1N1) strains were used
in experimenting with most of the HA subtypes in
avian influenza viruses (Table 1).
2. Sing/57 (H2N2) was used when doubly infecting
the cells with avian influenza viruses. Two
samples of A/Swine/Germany/81 were used, one
being singly infected, and the other being doubly 
infected with Sing/57 (Table 2).
3. A/Nanchang/933/95 (H3N2) was used when
doubly infecting the cells with avian strains.
A/Swine/Germany/81 was used for two samples,
similar to the previous set (Table 3).
Each sample was treated with 1μg/ml of TCPK and 
2 ml of 4% bovine serum.1  The viruses were incubated 
for 20 hours before they were split into two groups 
- selection and no selection. The “selection” groups
were diluted with hyperimmune antisera to isolate
against human HA’s (αH2). The “no selection” group
were used without further treatment (Figure 1).
The infected MDCK cells were treated with 0.9% agar 
and 4% bovine serum albumin and 0.5 μg of TCPK/
ml. The “selection” group had 4μg/ml of amantadine
in its agar overlay. After leaving the plaques for 3 days
at 37°C, certain plaques were observed and stained
with 0.1% crystal violet containing 10% formaldehyde.1 
Plaques that needed further purification were dissolved
in 1 ml of PBS, until ready for staining and observation.
RESULTS
(Am+ human PR8 strains) X (Am- avian influenza A 
viruses)(1) 
According to Table 1, the recombinants were able 
to produce many, well-distinct plaques. The results 
indicated that amantadine-resistant human PR8 strain 
and amantadine-sensitive avian influenza A viruses 
were able to reassort strains that replicate well. 
(Am+ human Singapore strain) X (Am- avian 
Influenza A viruses)(1)  
Most of the reassortments were produced few 
plaques, and were not viable (Table 2). The HA in the 
avian-like swine influenza viruses (H1N1) were more 
successful in cooperating with the HA in Sing/57 than 
the avian strains.
(Am+ human Nanchang strain) X (Am- avian 
influenza A viruses)(1)  
As presented in Table 3, the recombinants were 
unable to replicate efficiently; the overall performance 
was worse than the second set with the Singapore 
1957(H2N2) strain. Scholtissek et al. tested the 
human Nanchang strain with two different avian-like 
swine strains with similarly poor results.
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Table 1: Plaque yields (PFU) and maximum plaque 
diameters after a 20-h single or double infection with 
human PR8 and avian influenza A viruses.
Table 2: Plaque yields (PFU) and maximum plaque after 
single or dougle infection of MDCK cells with the human 
Singapore and avain or swine influenza A viruses.
Figure 1: Experimental design of double infection of 
MDCK cells and selection of influenza virus reassortants 
that carry the HA gene of the avain virus and the M gene of 
the amantadine-resistant variant of the human Singapore 
influenza virus. The hyperimmune antiserum (αH2) was 
directed against the HA of the human Singapore virus.
DISCUSSION
If the reassortants produce a great yield in clear plaques, 
it implies that the parent viruses successfully exchanged 
genomes and that their HA genes are homologous.
Data Interpretation
It was concluded that in order to produce a 
highly virulent strain, the human strain must be 
phylogenetically similar to the avian strain. This can be 
observed with the PR8 strains, as most reassortants 
were able to provide similar-sized plaques as their 
parent viruses (no selection). All the reassortants 
were sequenced to find that they contained the human 
M genes of PR8. The less homologous the parent 
viruses, the less compatible the avian and human 
HA. Referring to table 3 with the Nanchang/95 strain, 
none of the reassortants were able to produce viable 
plaques, indicating poor cooperation. By successfully 
Table 1. Table from Scholtissek et al. (2002) to illustrate plaque yields and 
diameters for human strains of PR8 and avian influenza A. From Cooperation 
between the Hemagglutinin of Avian Viruses and the Matrix Protein of Human 
Influenza A Viruses Christoph Scholtissek,  Jürgen Stech, Scott Krauss, 
and Robert G. Webster J. Virol. February 2002 76:1781-1786; doi:10.1128/
JVI.76.4.1781-1786.2002
a Anti-HI antiserum (1:100 dilution in PBS) was used to select against human HA, and amantadine 
(4 μg/ml in the agar overlay)  was used to select against avian M genes.
b The PR8 virus is naturally amantadine resistant (5).
a Anti-H2 antiserum (1:200 dilution in PBS) was used to select against human HA, and amantadine 
(4 μg/ml in the agar overlay)  was used to select against avian and swine M genes.
b An amantadine-resistant Singapore variant was used.
Figure 1. Scholtissek et al.’s (2002) experimental design to test for 
compatibility between human M-gene and avian HA. From Cooperation 
between the Hemagglutinin of Avian Viruses and the Matrix Protein of 
Human Influenza A Viruses Christoph Scholtissek,  Jürgen Stech, Scott 
Krauss, and Robert G. Webster J. Virol. February 2002 76:1781-1786; 
doi:10.1128/JVI.76.4.1781-1786.2002
Table 2. Table from Scholtissek et al. (2002) to illustrate plaque yields 
and diameters for human Singapore strain and avian influenza A. From 
Cooperation between the Hemagglutinin of Avian Viruses and the Matrix 
Protein of Human Influenza A Viruses Christoph Scholtissek,  Jürgen 
Stech, Scott Krauss, and Robert G. Webster J. Virol. February 2002 
76:1781-1786; doi:10.1128/JVI.76.4.1781-1786.2002
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Table 3: Plaque yields (PFU) and maximum plaque sizes 
after single or double infection of MDCK cells with the 
human Nanchang and avain or swine influenza A viruses.
Figure 2: Host and lineage origins for the gene segments 
of the 2009 A(H1N1) virus: PB2, PB1, PA, HA, NP, NA, M, 
NS. Color of gene segment in circle indicates host.
a Anti-H3 antiserum (1:100 dilution in PBS) was used to select against human HA, and amantadine 
(4 μg/ml in the agar overlay)  was used to select against avian and swine M genes.
b An amantadine-resistant Nanchang variant was used.
c The anti-H3 antiserum used did not neutralize the A/Duck/Uktraine/63 (H3N8) virus.
Table 3. Table from Scholtissek et al. (2002) to illustrate plaque yields 
and diameters for human Nanchang strain and avian influenza A. From 
Cooperation between the Hemagglutinin of Avian Viruses and the Matrix 
Protein of Human Influenza A Viruses Christoph Scholtissek,  Jürgen 
Stech, Scott Krauss, and Robert G. Webster J. Virol. February 2002 
76:1781-1786; doi:10.1128/JVI.76.4.1781-1786.2002
Figure 2. Host and lineage origins for the gene segments of the 2009 
A(H1N1) virus: PB2, PB1, PA, HA, NP, NA, M, NS. Colour of the 
gene segment indicates the host. From R. J. Garten, C. T. Davis et. 
al. SCIENCE. 325, 5937 (2009). Reprinted with permission from the 
American Association for the Advancement of Science (AAAS).
forming a stable virus population within a mammalian 
host, the avian influenza virus forms a stable lineage. 
It increases the chances of surpassing the species 
barrier that prevents it from easily infecting humans. 
This finding is illustrated in Table 2, where only a few 
avian and avian-like swine strains were successful in 
recombination resulting in reasonably-sized plaques. 
Errors 
Although experiments were conducted twice to ensure 
that the data were reproducible, unexpected results 
occurred. For example, the evolution of plaques to 
become amantadine-sensitive was possible due to 
the lack of amantadine present and the nature of 
heterozygotic M-genes which determine the virus’ 
resistance. Another explanation would be the chance 
of spontaneous mutation where a rare amantadine-
resistant variant of the avian influenza viruses were 
to form.1 The experimental model required human 
influenza viruses to be (Am+) and therefore, it would 
have skewed the survival rate of the cells.
Critical Analysis of Experimental Procedure 
It is interesting that the Scholtissek et al. model 
assumes that avian HA and human M genes are the 
most relevant in determining cooperation between 
parent viruses. The influenza virion contains 8 main 
segments of viral RNA, two of which are HA and M. 
Recent studies on the origin of previous pandemic 
strains imply that 1918 A(H1N1), 1957 A(H2N2) and 
1968 A(H3N2) were products of complex reassortment.
(3-4) For instance, the 2009 A(H1N1) pandemic is 
believed to have been caused by the recombinant of 
at least three different swine viruses that were stable 
and circulating in Eurasia and America(4,6) (Figure 2), 
and not a simple reassortment between an avian and 
a human strain. Amongst the parent viruses, one of the 
Eurasian swine viruses’ neuraminidase (NA) and M 
genes derived from a wholly-avian influenza virus.4  This 
interaction is similar to the second set of experiments 
where the avian-like swine viruses were successfully 
reassorted with the Sing/57 (H2N2) strain, except with 
different genes. This implies that pandemic-planning 
should not focus on genetic recombination, but must 
consider reservoirs and how easily the virus may infect 
and accumulate within the host.
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FUTURE DIRECTIONS
Although the chances of an influenza A pandemic 
circulating with HA subtypes other than 1, 2, and 3 is 
not possible, it is important to conduct further research 
in pandemic planning to prepare for future outbreaks. 
It takes series of multiple complex reassortments 
between many different stable circulating strains 
to form a potentially highly pathogenic novel strain. 
Further research needs to be done on influenza A 
reservoirs. Examples include swine and Eurasian 
swine as they have both “avian” type and “human” 
type HA receptors, enabling a low species barrier for 
mixing and distribution of different influenza A strains. 
Future research will be effective in seeking potential 
causes and virulence in pandemics.
ABBREVIATIONS
HA Hemagglutinin
M Matrix
TCPK Tosylsulfonyl Phenylalanyl Chloromethyl 
Ketone-treated Trypsin
PB2 Polymerase Basic 2
PA Polymerase Acidic
PBS Phosphate-Buffered Saline
AM+ Amantadine-Resistant
AM- Amantadine-Sensitive
MDCK Madin-Darby Canine Kidney Cells
NA Neuraminidase
PB1 Polymerase Basic 1
NP Nucleoprotein
NS Nonstructural Gene
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